Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR/cytokine-coated nanogold.
Angelo CortiAngelina SacchiAnna Maria GasparriMatteo MonieriGiulia AnderluzziBarbara ColomboAlessandro GoriAnna MondinoFlavio CurnisPublished in: Journal of nanobiotechnology (2021)
IsoDGR-coated gold nanospheres can be exploited as a versatile platform for single- or multi-cytokine delivery to cells of the tumor vasculature. Extremely low doses of isoDGR-coated nanodrugs functionalized with TNF or TNF plus IL12 can enhance doxorubicin anti-tumor activity.